Clinical Trial Update: A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, randomized study evaluating brivaracetam monotherapy for partial-onset seizures in adults was terminated but results were posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: TERMINATED | Results posted: 2016-04-13